ID   MRCKG_HUMAN             Reviewed;        1551 AA.
AC   Q6DT37; O00565;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-MAR-2010, sequence version 2.
DT   15-MAR-2017, entry version 127.
DE   RecName: Full=Serine/threonine-protein kinase MRCK gamma;
DE            EC=2.7.11.1;
DE   AltName: Full=CDC42-binding protein kinase gamma;
DE   AltName: Full=DMPK-like gamma;
DE   AltName: Full=Myotonic dystrophy kinase-related CDC42-binding kinase gamma;
DE            Short=MRCK gamma;
DE            Short=MRCKG;
DE            Short=Myotonic dystrophy protein kinase-like gamma;
DE   AltName: Full=Myotonic dystrophy protein kinase-like alpha;
GN   Name=CDC42BPG {ECO:0000312|HGNC:HGNC:29829}; Synonyms=DMPK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAT67172.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon {ECO:0000269|PubMed:15194684};
RX   PubMed=15194684; DOI=10.1074/jbc.M405252200;
RA   Ng Y., Tan I., Lim L., Leung T.;
RT   "Expression of the human myotonic dystrophy kinase-related Cdc42-
RT   binding kinase gamma is regulated by promoter DNA methylation and Sp1
RT   binding.";
RL   J. Biol. Chem. 279:34156-34164(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:CAA73006.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 113-401.
RX   PubMed=9341881; DOI=10.1007/s004390050562;
RA   Kedra D., Seroussi E., Fransson I., Trifunovic J., Clark M.,
RA   Lagercrantz J., Blennow E., Mehlin H., Dumanski J.;
RT   "The germinal centre kinase gene and a novel CDC25-like gene are
RT   located in the vicinity of the PYGM gene on 11q13.";
RL   Hum. Genet. 100:611-619(1997).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1482, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-168; PHE-280; PRO-362 AND ASP-537.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May act as a downstream effector of CDC42 in
CC       cytoskeletal reorganization. Contributes to the actomyosin
CC       contractility required for cell invasion, through the regulation
CC       of MYPT1 and thus MLC2 phosphorylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q5VT25, ECO:0000269|PubMed:15194684}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:15194684}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15194684};
CC   -!- ENZYME REGULATION: Maintained in an inactive, closed conformation
CC       by an interaction between the kinase domain and the negative
CC       autoregulatory C-terminal coiled-coil region. Agonist binding to
CC       the phorbol ester binding site disrupts this, releasing the kinase
CC       domain to allow N-terminus-mediated dimerization and kinase
CC       activation by transautophosphorylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q5VT25}.
CC   -!- SUBUNIT: Homodimer and homotetramer via the coiled coil regions.
CC       Interacts tightly with GTP-bound but not GDP-bound CDC42 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-689124, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15194684}.
CC       Note=Concentrates at the leading edge of cells.
CC   -!- TISSUE SPECIFICITY: Expressed in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:15194684}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. DMPK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY648038; AAT67172.1; -; mRNA.
DR   EMBL; AP001187; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y12337; CAA73006.1; -; mRNA.
DR   CCDS; CCDS31601.1; -.
DR   RefSeq; NP_059995.2; NM_017525.2.
DR   UniGene; Hs.293590; -.
DR   ProteinModelPortal; Q6DT37; -.
DR   SMR; Q6DT37; -.
DR   BioGrid; 120719; 5.
DR   IntAct; Q6DT37; 4.
DR   MINT; MINT-3976275; -.
DR   STRING; 9606.ENSP00000345133; -.
DR   BindingDB; Q6DT37; -.
DR   ChEMBL; CHEMBL5615; -.
DR   GuidetoPHARMACOLOGY; 1506; -.
DR   iPTMnet; Q6DT37; -.
DR   PhosphoSitePlus; Q6DT37; -.
DR   BioMuta; CDC42BPG; -.
DR   DMDM; 290457650; -.
DR   EPD; Q6DT37; -.
DR   MaxQB; Q6DT37; -.
DR   PaxDb; Q6DT37; -.
DR   PeptideAtlas; Q6DT37; -.
DR   PRIDE; Q6DT37; -.
DR   Ensembl; ENST00000342711; ENSP00000345133; ENSG00000171219.
DR   GeneID; 55561; -.
DR   KEGG; hsa:55561; -.
DR   UCSC; uc001obs.5; human.
DR   CTD; 55561; -.
DR   GeneCards; CDC42BPG; -.
DR   H-InvDB; HIX0035842; -.
DR   HGNC; HGNC:29829; CDC42BPG.
DR   HPA; HPA027382; -.
DR   HPA; HPA061836; -.
DR   MIM; 613991; gene.
DR   neXtProt; NX_Q6DT37; -.
DR   OpenTargets; ENSG00000171219; -.
DR   PharmGKB; PA134901493; -.
DR   eggNOG; KOG0612; Eukaryota.
DR   eggNOG; ENOG410XR1Q; LUCA.
DR   GeneTree; ENSGT00760000118994; -.
DR   HOGENOM; HOG000294133; -.
DR   HOVERGEN; HBG055933; -.
DR   InParanoid; Q6DT37; -.
DR   KO; K16307; -.
DR   OMA; FRNHPFF; -.
DR   OrthoDB; EOG091G09EX; -.
DR   PhylomeDB; Q6DT37; -.
DR   TreeFam; TF313551; -.
DR   SignaLink; Q6DT37; -.
DR   ChiTaRS; CDC42BPG; human.
DR   GenomeRNAi; 55561; -.
DR   PRO; PR:Q6DT37; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000171219; -.
DR   CleanEx; HS_CDC42BPG; -.
DR   Genevisible; Q6DT37; HS.
DR   GO; GO:0031252; C:cell leading edge; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   CDD; cd00029; C1; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR033235; MRCK_gamma.
DR   InterPro; IPR014930; Myotonic_dystrophy_kinase_coil.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22988:SF47; PTHR22988:SF47; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF08826; DMPK_coil; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   ProDom; PD011252; Myotonic_dystrophy_kinase_coil; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Coiled coil; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN         1   1551       Serine/threonine-protein kinase MRCK
FT                                gamma.
FT                                /FTId=PRO_0000086397.
FT   DOMAIN       71    337       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:15194684}.
FT   DOMAIN      338    408       AGC-kinase C-terminal.
FT   DOMAIN      947   1066       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN     1092   1366       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   DOMAIN     1437   1450       CRIB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00057}.
FT   NP_BIND      77     85       ATP. {ECO:0000250|UniProtKB:P54265,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ZN_FING     878    927       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COILED      406    678       {ECO:0000255}.
FT   COILED      730    802       {ECO:0000255}.
FT   ACT_SITE    195    195       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P54265,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING     100    100       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:15194684}.
FT   MOD_RES     216    216       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     228    228       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     234    234       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES    1482   1482       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     168    168       P -> L (in dbSNP:rs34454471).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040840.
FT   VARIANT     280    280       S -> F (in a glioblastoma multiforme
FT                                sample; somatic mutation;
FT                                dbSNP:rs770462360).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040841.
FT   VARIANT     362    362       T -> P (in dbSNP:rs55688429).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040842.
FT   VARIANT     537    537       A -> D (in dbSNP:rs34241745).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040843.
FT   VARIANT    1135   1135       Q -> R (in dbSNP:rs3741395).
FT                                /FTId=VAR_057105.
FT   CONFLICT    628    628       P -> R (in Ref. 1; AAT67172).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1551 AA;  172459 MW;  A6D042D5D11318D7 CRC64;
     MERRLRALEQ LARGEAGGCP GLDGLLDLLL ALHHELSSGP LRRERSVAQF LSWASPFVSK
     VKELRLQRDD FEILKVIGRG AFGEVTVVRQ RDTGQIFAMK MLHKWEMLKR AETACFREER
     DVLVKGDSRW VTTLHYAFQD EEYLYLVMDY YAGGDLLTLL SRFEDRLPPE LAQFYLAEMV
     LAIHSLHQLG YVHRDVKPDN VLLDVNGHIR LADFGSCLRL NTNGMVDSSV AVGTPDYISP
     EILQAMEEGK GHYGPQCDWW SLGVCAYELL FGETPFYAES LVETYGKIMN HEDHLQFPPD
     VPDVPASAQD LIRQLLCRQE ERLGRGGLDD FRNHPFFEGV DWERLASSTA PYIPELRGPM
     DTSNFDVDDD TLNHPGTLPP PSHGAFSGHH LPFVGFTYTS GSHSPESSSE AWAALERKLQ
     CLEQEKVELS RKHQEALHAP TDHRELEQLR KEVQTLRDRL PEMLRDKASL SQTDGPPAGS
     PGQDSDLRQE LDRLHRELAE GRAGLQAQEQ ELCRAQGQQE ELLQRLQEAQ EREAATASQT
     RALSSQLEEA RAAQRELEAQ VSSLSRQVTQ LQGQWEQRLE ESSQAKTIHT ASETNGMGPP
     EGGPQEAQLR KEVAALREQL EQAHSHRPSG KEEALCQLQE ENRRLSREQE RLEAELAQEQ
     ESKQRLEGER RETESNWEAQ LADILSWVND EKVSRGYLQA LATKMAEELE SLRNVGTQTL
     PARPLDHQWK ARRLQKMEAS ARLELQSALE AEIRAKQGLQ ERLTQVQEAQ LQAERRLQEA
     EKQSQALQQE LAMLREELRA RGPVDTKPSN SLIPFLSFRS SEKDSAKDPG ISGEATRHGG
     EPDLRPEGRR SLRMGAVFPR APTANTASTE GLPAKPGSHT LRPRSFPSPT KCLRCTSLML
     GLGRQGLGCD ACGYFCHTTC APQAPPCPVP PDLLRTALGV HPETGTGTAY EGFLSVPRPS
     GVRRGWQRVF AALSDSRLLL FDAPDLRLSP PSGALLQVLD LRDPQFSATP VLASDVIHAQ
     SRDLPRIFRV TTSQLAVPPT TCTVLLLAES EGERERWLQV LGELQRLLLD ARPRPRPVYT
     LKEAYDNGLP LLPHTLCAAI LDQDRLALGT EEGLFVIHLR SNDIFQVGEC RRVQQLTLSP
     SAGLLVVLCG RGPSVRLFAL AELENIEVAG AKIPESRGCQ VLAAGSILQA RTPVLCVAVK
     RQVLCYQLGP GPGPWQRRIR ELQAPATVQS LGLLGDRLCV GAAGGFALYP LLNEAAPLAL
     GAGLVPEELP PSRGGLGEAL GAVELSLSEF LLLFTTAGIY VDGAGRKSRG HELLWPAAPM
     GWGYAAPYLT VFSENSIDVF DVRRAEWVQT VPLKKVRPLN PEGSLFLYGT EKVRLTYLRN
     QLAEKDEFDI PDLTDNSRRQ LFRTKSKRRF FFRVSEEQQK QQRREMLKDP FVRSKLISPP
     TNFNHLVHVG PANGRPGARD KSPAPEEKGR VARGSGPQRP HSFSEALRRP ASMGSEGLGG
     DADPMKRKPW TSLSSESVSC PQGSLSPATS LMQVSERPRS LPLSPELESS P
//
